Cary Street Partners Investment Advisory LLC Arch Therapeutics, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

  • $2.63 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$0.13 - $0.18 $650 - $900
-5,000 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$0.16 - $0.2 $800 - $1,000
5,000 New
5,000 $1,000

About Arch Therapeutics, Inc.

ARTH Quotes by TradingView
  • Ticker ARTH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,886,000
  • Market Cap $62.5M
  • Description
  • Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...
More about ARTH
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email